You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

autologous hematopoietic cell transplantation (HCT)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Nov 2, 2022

Multiple Myeloma Trial in Saint Louis (Uproleselan, Placebo, Melphalan)

Completed
  • Multiple Myeloma
  • Saint Louis, Missouri
    Washington University School of Medicine
Nov 22, 2022

Multiple Myeloma Trial in Tampa (biological, procedure, drug)

Active, not recruiting
  • Multiple Myeloma
  • Survivin Vaccine
  • +3 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 7, 2022

Autoimmune Disease, Neurologic Autoimmune Disease, Autologous Transplant Autoimmune Trial in Denver, Seattle (biological,

Recruiting
  • Autoimmune Disease
  • +18 more
  • Anti-Thymocyte Globulin
  • +9 more
  • Denver, Colorado
  • +2 more
Feb 1, 2023

Hematopoietic Cell Transplantation (HCT) Trial (Tributyrin)

Not yet recruiting
  • Hematopoietic Cell Transplantation (HCT)
  • Tributyrin
  • (no location specified)
Jul 11, 2023

Taste Function In Multiple Myeloma Patients Undergoing

Active, not recruiting
  • Multiple Myeloma
  • Oral microbiota assessment
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 23, 2023

Multiple Myeloma Trial in Houston (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Houston, Texas
    M D Anderson Cancer Center
Jan 5, 2023

Hematopoietic Cell Transplant Trial in Atlanta (Virtual exercise and rehabilitation program)

Not yet recruiting
  • Hematopoietic Cell Transplant
  • Virtual exercise and rehabilitation program
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Jul 5, 2023

Gastro-Intestinal Disorder Trial in Memphis (Fecal microbiota transplant (FMT))

Not yet recruiting
  • Gastro-Intestinal Disorder
  • Fecal microbiota transplant (FMT)
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Jan 9, 2023

Beta-Thalassemia Trial (CS-101 injection)

Not yet recruiting
  • Beta-Thalassemia
  • CS-101 injection
  • (no location specified)
Sep 27, 2023

Hematologic Malignancies Trial in Minneapolis (Haplo HCT <55 years old, Haplo HCT =55 years old, GVHD Prophylaxis)

Recruiting
  • Hematologic Malignancies
  • Haplo HCT <55 years old
  • +4 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Jan 25, 2023

Sinusoidal Obstruction Syndrome, Veno-occlusive Disease Trial (Defibrotide)

Not yet recruiting
  • Sinusoidal Obstruction Syndrome
  • Veno-occlusive Disease
  • (no location specified)
Aug 4, 2023

Risk HDS and HCT in Patients With Haemoblasts.

Recruiting
  • Cardiotoxicity
  • electrocardiography, echocardiography with the determination of global longitudinal strain, cardiopulmonary exercise test, and diagnostic of endothelial function by Angioscan
  • Moscow, Russian Federation
    Sechenov University
Aug 18, 2022

Well-being of Caregivers (Caregiver Strain Index) Trial in Durham (home care)

Recruiting
  • Well-being of Caregivers (Caregiver Strain Index)
  • home care
  • Durham, North Carolina
    Duke University Medical Center
Jan 25, 2023

Vascular, Endothelial, Endothelial Dysfunction Trial in Houston (Vendys II Device)

Recruiting
  • Vascular
  • +3 more
  • Vendys II Device
  • Houston, Texas
    M D Anderson Cancer Center
Jun 28, 2022

Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome, Multiple Organ Dysfunction Syndrome Trial in Los Angeles,

Completed
  • Thrombotic Microangiopathies
  • +2 more
  • Los Angeles, California
  • +2 more
Jan 17, 2023

Hemoglobinopathy (Disorder), Severe Aplastic Anemia, Bone Marrow Failure Syndrome Trial in Saint Petersburg (Haploidentical

Recruiting
  • Hemoglobinopathy (Disorder)
  • +2 more
  • Haploidentical Hematopoietic Cell Transplantation
  • Saint Petersburg, Florida
    Johns Hopkins All Children's Hospital
Sep 13, 2022

Acute Lymphoblastic Leukemia Trial in Houston (Blinatumomab, Hematopoietic Cell Transplantation)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 30, 2022

Hematologic Malignancy Trial in Duarte (B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010))

Recruiting
  • Hematologic Malignancy
  • B. infantis (PBCLN-014) and Human Milk Oligosaccharides (HMO) (PBCLN-010)
  • Duarte, California
    City of Hope
Oct 20, 2023

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

Recruiting
  • Multiple Myeloma
  • Total Marrow irradiation，TMI
  • Autologous hematopoietic stem cell transplantation
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Jul 24, 2023

Allogeneic Hematopoietic Cell Transplantation (HCT) Trial in Boston (FMT, Placebo)

Terminated
Has Results
  • Allogeneic Hematopoietic Cell Transplantation (HCT)
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Nov 3, 2021

Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

Not yet recruiting
  • Systemic Sclerosis
  • SARS-CoV 2 Vaccination
    • (no location specified)
    Jul 24, 2023

    ASCT Versus Chemotherapy as First-Line Consolidation Therapy

    Completed
    • T-cell Lymphoma Adults
    • consolidation with ASCT
    • (no location specified)
    Nov 25, 2023

    Bone Marrow Transplant Complications, Hematologic Malignancy Trial in Boston (CARE Application, Usual Care)

    Not yet recruiting
    • Bone Marrow Transplant Complications
    • Hematologic Malignancy
    • CARE Application
    • Usual Care
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    Feb 1, 2023